AUROPHARMA.NS

Aurobindo Pharma Limited [AUROPHARMA.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

AUROPHARMA.NS Stock Summary

Top 10 Correlated ETFs

AUROPHARMA.NS


Top 10 Correlated Stocks

AUROPHARMA.NS


In the News

AUROPHARMA.NS Financial details

Company Rating
Buy
Market Cap
597.57B
Income
27.7B
Revenue
275.91B
Book val./share
-
Cash/share
-
Dividend
6
Dividend %
0.53%
Employees
23.45K
Optionable
No
Shortable
Yes
Earnings
25 May 2024
P/E
28.56
Forward P/E
16.79
PEG
62.65
P/S
2.47
P/B
2.36
P/C
-
P/FCF
-11469.12
Quick Ratio
0.93
Current Ratio
1.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
47.25
EPS next Y
64.85
EPS next Q
15.35
EPS this Y
-27.2%
EPS next Y
37.25%
EPS next 5Y
53.65%
EPS last 5Y
-4%
Revenue last 5Y
5.07%
Revenue Q/Q
1.69%
EPS Q/Q
25.02%
-
-
-
-
SMA20
-0.86%
SMA50
-7.53%
SMA100
19.58%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
17%
ROC
0.11%
Gross Margin
54%
Oper. Margin
13%
Profit Margin
9%
Payout
-
Shs Outstand
585.94M
Shs Float
281.54M
-
-
-
-
Target Price
-
52W Range
485.0-1177.1
52W High
-7.5%
52W Low
+124.48%
RSI
59
Rel Volume
0.75
Avg Volume
2.75M
Volume
2.06M
Perf Week
6.99%
Perf Month
9.3%
Perf Quarter
20.86%
Perf Half Y
24.62%
-
-
-
-
Beta
0.581
-
-
Volatility
31.55%, 25.5%
Prev Close
1.72%
Price
1088.75
Change
3.69%

AUROPHARMA.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
328.14388.06419.12398.79420.13
Net income per share
40.3648.5691.0545.232.9
Operating cash flow per share
27.6874.7756.8185.6140.73
Free cash flow per share
0.2850.3524.8339.46-5.69
Cash per share
32.9248.5195.9377.78111.37
Book value per share
237.08286.9374.27419.43458.07
Tangible book value per share
184.07231.16321.01357.73391.34
Share holders equity per share
237.08286.9374.27419.43458.07
Interest debt per share
121.48109.9695.7356.5992.62
Market cap
464.24B242.08B516.39B391.73B303.57B
Enterprise value
515.36B277.46B518.15B382.89B312.47B
P/E ratio
19.638.519.6814.7915.75
Price to sales ratio
2.411.062.11.681.23
POCF ratio
28.625.5315.517.8112.72
PFCF ratio
2.79K8.2135.4916.94-90.99
P/B Ratio
3.341.442.351.591.13
PTB ratio
3.341.442.351.591.13
EV to sales
2.681.222.111.641.27
Enterprise value over EBITDA
12.815.649.638.297.82
EV to operating cash flow
31.776.3315.577.6313.09
EV to free cash flow
3.1K9.435.6116.56-93.65
Earnings yield
0.050.120.10.070.06
Free cash flow yield
00.120.030.06-0.01
Debt to equity
0.50.370.250.130.2
Debt to assets
0.260.220.160.10.13
Net debt to EBITDA
1.270.720.03-0.190.22
Current ratio
1.281.441.862.221.87
Interest coverage
21.9427.8274.7689.7518.16
Income quality
0.521.170.451.490.91
Dividend Yield
00.0100.010.01
Payout ratio
0.060.060.040.10.23
Sales general and administrative to revenue
0.020.030.030.030.03
Research and developement to revenue
00.01000
Intangibles to total assets
0.120.110.090.110.1
Capex to operating cash flow
-0.99-0.33-0.56-0.54-1.14
Capex to revenue
-0.08-0.06-0.08-0.12-0.11
Capex to depreciation
-2.4-1.48-1.78-2.4-2.19
Stock based compensation to revenue
00000
Graham number
464559.86875.62653.08582.27
ROIC
0.120.130.120.090.06
Return on tangible assets
0.10.110.170.090.05
Graham Net
-43.3-36.4417.1539.7520.88
Working capital
33.22B50.26B91.58B99.67B100.52B
Tangible asset value
107.85B135.45B188.09B209.61B229.3B
Net current asset value
28.03B42.97B78.99B87.75B85.08B
Invested capital
0.50.370.250.130.2
Average receivables
53.9B51.75B40.56B40.92B45.48B
Average payables
26.52B26.11B26.7B27.49B32.87B
Average inventory
65.52B74.73B83.63B82.9B80.33B
Days sales outstanding
113.2370.3855.3969.6168.8
Days payables outstanding
112.1595.42103.0197.3125.12
Days of inventory on hand
303.54288.69332.71271.9275.08
Receivables turnover
3.225.196.595.245.31
Payables turnover
3.253.833.543.752.92
Inventory turnover
1.21.261.11.341.33
ROE
0.170.170.240.110.07
Capex per share
-27.4-24.42-31.98-46.16-46.43

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
109.02108.86115.89122.04124.57
Net income per share
8.388.649.7412.9216.04
Operating cash flow per share
10.97-0.111.1525.614.5
Free cash flow per share
10.97-0.111.150.0814.5
Cash per share
110.45111.37106.37126.920
Book value per share
435.89458.07458.27481.090
Tangible book value per share
0391.340415.750
Share holders equity per share
435.89458.07458.27481.090
Interest debt per share
0.7791.170.97114.631.29
Market cap
256.82B303.57B426.18B535.75B630.51B
Enterprise value
321.53B312.47B488.51B560.92B630.51B
P/E ratio
13.0714.9918.6717.6916.84
Price to sales ratio
4.024.766.287.498.67
POCF ratio
39.95-5.28K65.2535.7174.48
PFCF ratio
39.95-5.28K65.2511.35K74.48
P/B Ratio
1.011.131.591.90
PTB ratio
1.011.131.591.90
EV to sales
5.034.97.197.848.67
Enterprise value over EBITDA
30.7327.6238.6235.9335.8
EV to operating cash flow
50.02-5.43K74.837.3974.48
EV to free cash flow
50.02-5.43K74.811.88K74.48
Earnings yield
0.020.020.010.010.01
Free cash flow yield
0.0300.0200.01
Debt to equity
00.200.240
Debt to assets
00.1300.150
Net debt to EBITDA
6.180.794.931.610
Current ratio
01.8701.810
Interest coverage
16.1314.1314.5916.7817.71
Income quality
1.31-0.011.141.980.9
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.060.060.060.040.05
Intangibles to total assets
00.100.090
Capex to operating cash flow
000-10
Capex to revenue
000-0.210
Capex to depreciation
000-2.010
Stock based compensation to revenue
00000
Graham number
286.75298.41316.923740
ROIC
0.020.020.020.020
Return on tangible assets
00.0100.020
Graham Net
110.4520.88106.37-2.420
Working capital
64.72B100.52B62.33B105.43B0
Tangible asset value
0229.3B0243.6B0
Net current asset value
64.72B85.08B62.33B78.26B0
Invested capital
00.200.240
Average receivables
20.16B23.2B23.2B23.39B23.39B
Average payables
17.58B19.36B19.36B22.53B22.53B
Average inventory
39.45B42.56B42.56B46.41B46.41B
Days sales outstanding
065.47058.880
Days payables outstanding
0118.870125.280
Days of inventory on hand
0261.350258.10
Receivables turnover
01.3701.530
Payables turnover
00.7600.720
Inventory turnover
00.3400.350
ROE
0.020.020.020.030
Capex per share
000-25.520

AUROPHARMA.NS Frequently Asked Questions

What is Aurobindo Pharma Limited stock symbol ?

Aurobindo Pharma Limited is a IN stock and trading under the symbol AUROPHARMA.NS

What is Aurobindo Pharma Limited stock quote today ?

Aurobindo Pharma Limited stock price is $1088.75 today.

Is Aurobindo Pharma Limited stock public?

Yes, Aurobindo Pharma Limited is a publicly traded company.

Something similar